MENU
TRML
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tourmaline Bio (TRML) Ownership - Who owns Tourmaline Bio?
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases... Show more
Profile
Industry
N/A
Address
27 West 24th Street
Phone
+1 646 481-9832
Employees
44
Web
https://www.tourmalinebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
393.55M
P/E Ratio
N/A
Total Cash
249.31M
Projected Growth
N/A
Total Debt
196K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.70
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TRML
Capitalization
394M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
249M
Total Cash/Share
9.70
Total Debt
196K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
280M
P/B Ratio
1.41
Cash Flow
N/A
Earnings
-3.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
33.87
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-98.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-25.63
Shares Held By Institutions
519M
Shares Outstanding - Current
25.7M
Total Liabilities
7.64M
Total Volume MTD
N/A
Value
1
Gain YTD
-24.458
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
27 West 24th Street
Phone
+1 646 481-9832
Employees
44
Web
https://www.tourmalinebio.com